ABHD2

In the presence of Progesterone (or Pregnenolone Sulfate,{{Cite journal|last1=Mannowetz|first1=Nadja|last2=Miller|first2=Melissa R.|last3=Lishko|first3=Polina V.|date=2017-05-30|title=Regulation of the sperm calcium channel CatSper by endogenous steroids and plant triterpenoids|journal=Proceedings of the National Academy of Sciences|language=en|volume=114|issue=22|pages=5743–5748|doi=10.1073/pnas.1700367114|issn=0027-8424|pmid=28507119|pmc=5465908|doi-access=free|bibcode=2017PNAS..114.5743M }}) it cleaves 2-arachidonoylglycerol (2AG) into glycerol and arachidonic acid (AA).{{Cite journal|last1=Miller|first1=Melissa R.|last2=Mannowetz|first2=Nadja|last3=Iavarone|first3=Anthony T.|last4=Safavi|first4=Rojin|last5=Gracheva|first5=Elena O.|last6=Smith|first6=James F.|last7=Hill|first7=Rose Z.|last8=Bautista|first8=Diana M.|last9=Kirichok|first9=Yuriy|date=2016-04-29|title=Unconventional endocannabinoid signaling governs sperm activation via the sex hormone progesterone|journal=Science|language=en|volume=352|issue=6285|pages=555–559|doi=10.1126/science.aad6887|issn=0036-8075|pmid=26989199|pmc=5373689|bibcode=2016Sci...352..555M}} 2AG inhibits sperm calcium channel CatSper, and so when ABHD2 removes 2AG calcium flows into the cell through the CatSper channel, leading to hyperactivation.

ABHD2 is inhibited by testosterone, (as well as hydrocortisone, and the plant triterpenoids lupeol and pristimerin) which may prevent premature hyperactivation.

This gene encodes a protein containing an alpha/beta hydrolase fold, which is a catalytic domain found in a very wide range of enzymes. Alternative splicing of this gene results in two transcript variants encoding the same protein.

The ABHD2 gene is down regulated in the lungs of people with Emphysema. Analysis of ABHD2 deficiency in mice found a decrease in phosphatidylcholine levels. The mice developed emphysema which was attributed to an increase in macrophage infiltration, increased inflammatory cytokine levels, an imbalance of protease/anti-protease, and an increase in cell death. This research suggests that ABHD2 is important in maintaining the structural integrity of the lungs, and that disruption of phospholipid metabolism in the alveoli may lead to the development of emphysema.{{cite journal | vauthors = Jin S, Zhao G, Li Z, Nishimoto Y, Isohama Y, Shen J, Ito T, Takeya M, Araki K, He P, Yamamura K | title = Age-related pulmonary emphysema in mice lacking alpha/beta hydrolase domain containing 2 gene | journal = Biochemical and Biophysical Research Communications | volume = 380 | issue = 2 | pages = 419–24 | date = Mar 2009 | pmid = 19250629 | doi = 10.1016/j.bbrc.2009.01.098 }} Increased expression has also been seen in the lungs of smokers.{{cite journal | title=Finding genes discriminating smokers from non-smokers by applying a growing self-organizing clustering method to large airway epithelium cell microarray data. | author=Shahdoust M | journal=Asian Pac. J. Cancer Prev. | year=2013 | volume=14 | issue=1 | pages=111–6 | pmid=23534707 | doi=10.7314/apjcp.2013.14.1.111|display-authors=etal| doi-access=free }}

ABHD2 is also expressed in atherosclerotic lesions. Expression has been found to be higher in patients with unstable angina than in patients with stable angina.{{cite journal | vauthors = Miyata K, Nakayama M, Mizuta S, Hokimoto S, Sugamura K, Oshima S, Oike Y, Sugiyama S, Ogawa H, Yamamura K | title = Elevated mature macrophage expression of human ABHD2 gene in vulnerable plaque | journal = Biochemical and Biophysical Research Communications | volume = 365 | issue = 2 | pages = 207–13 | date = Jan 2008 | pmid = 17980156 | doi = 10.1016/j.bbrc.2007.10.127 }}

Up-regulation of ABHD2 has been observed in cells transfected with Hepatitis B virus (HBV) DNA (HepG2.2.15 cells). Expression was down-regulated by the drug lamivudine, used in the treatment of hepatitis B. It has been suggested that ABHD2 has an important role in HBV propagation and could be a potential drug target in the treatment of hepatitis B.{{cite journal | vauthors = Ding X, Yang J, Wang S | title = Antisense oligonucleotides targeting abhydrolase domain containing 2 block human hepatitis B virus propagation | journal = Oligonucleotides | volume = 21 | issue = 2 | pages = 77–84 | date = Mar–Apr 2011 | pmid = 21466387 | doi = 10.1089/oli.2011.0280 }}

Suppression of ABHD2 has been linked to poor prognoses in ovarian cancer and resistance to platinum-based chemotherapy drugs.{{Cite journal|last1=Yamanoi|first1=Koji|last2=Matsumura|first2=Noriomi|last3=Murphy|first3=Susan K.|last4=Baba|first4=Tsukasa|last5=Abiko|first5=Kaoru|last6=Hamanishi|first6=Junzo|last7=Yamaguchi|first7=Ken|last8=Koshiyama|first8=Masafumi|last9=Konishi|first9=Ikuo|last10=Mandai|first10=Masaki|date=2016-06-13|title=Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer|journal=Oncotarget|volume=7|issue=30|pages=47620–47636|doi=10.18632/oncotarget.9951|pmid=27323405|pmc=5216966|issn=1949-2553|doi-access=free}}

{{reflist}}

• {{UCSC gene info|ABHD2}}

{{refbegin | 2}}

• {{cite journal | vauthors = Miyata K, Nakayama M, Mizuta S, Hokimoto S, Sugamura K, Oshima S, Oike Y, Sugiyama S, Ogawa H, Yamamura K | title = Elevated mature macrophage expression of human ABHD2 gene in vulnerable plaque | journal = Biochemical and Biophysical Research Communications | volume = 365 | issue = 2 | pages = 207–213 | date = Jan 2008 | pmid = 17980156 | doi = 10.1016/j.bbrc.2007.10.127 }}
• {{cite journal | vauthors = Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, Ishii S, Sugiyama T, Saito K, Isono Y, Irie R, Kushida N, Yoneyama T, Otsuka R, Kanda K, Yokoi T, Kondo H, Wagatsuma M, Murakawa K, Ishida S, Ishibashi T, Takahashi-Fujii A, Tanase T, Nagai K, Kikuchi H, Nakai K, Isogai T, Sugano S | title = Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes | journal = Genome Research | volume = 16 | issue = 1 | pages = 55–65 | date = Jan 2006 | pmid = 16344560 | pmc = 1356129 | doi = 10.1101/gr.4039406 }}
• {{cite journal | vauthors = Edgar AJ, Polak JM | title = Cloning and tissue distribution of three murine alpha/beta hydrolase fold protein cDNAs | journal = Biochemical and Biophysical Research Communications | volume = 292 | issue = 3 | pages = 617–625 | date = Apr 2002 | pmid = 11922611 | doi = 10.1006/bbrc.2002.6692 }}
• {{cite journal | vauthors = Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S | title = Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library | journal = Gene | volume = 200 | issue = 1–2 | pages = 149–156 | date = Oct 1997 | pmid = 9373149 | doi = 10.1016/S0378-1119(97)00411-3 }}
• {{cite journal | vauthors = Maruyama K, Sugano S | title = Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides | journal = Gene | volume = 138 | issue = 1–2 | pages = 171–174 | date = Jan 1994 | pmid = 8125298 | doi = 10.1016/0378-1119(94)90802-8 }}
• {{cite journal | vauthors = Rapiejko PJ, George ST, Malbon CC | title = Primary structure of a human protein which bears structural similarities to members of the rhodopsin/beta-adrenergic receptor family | journal = Nucleic Acids Research | volume = 16 | issue = 17 | pages = 8721 | date = Sep 1988 | pmid = 2843827 | pmc = 338599 | doi = 10.1093/nar/16.17.8721 }}

{{refend}}

{{DEFAULTSORT:Abhd2}}

Category:Enzymes

Category:Enzymes of unknown structure

Category:Hydrolases

Category:Membrane proteins

Category:Genes on human chromosome 15